Ep. 29: “Immuno-Oncology Therapeutics” Featuring Dr. Michael Alonso
Dr. Michael Alonso is a Scientific Co-Founder, and Vice President of Immunology & Pharmacology at Bolt Biotherapeutics, a biotechnology company developing immunotherapies that activate myeloid cells. He discusses targeting tumors…
Patricia ThomsonMay 24, 2022

